Factors Related to Adherence to Therapy in Patients Using Oral Anticoagulants in Outpatient Follow-Up
DOI:
https://doi.org/10.5294/aqui.2024.24.4.6Keywords:
Anticoagulants, Cooperation and Adherence to treatment, Health promotion, cardiovascular nursingAbstract
Introduction: Factors related to therapy adherence can influence the complexity of care for patients using anticoagulants. Objective: To identify the factors related to patient adherence to oral anticoagulant treatment in outpatient follow-up. Materials and Methods: This is a descriptive, cross-sectional study with a quantitative approach, conducted at the oral anticoagulation outpatient clinic of a cardiology reference hospital in northern and northeastern Brazil. A questionnaire with sociodemographic and clinical variables and an instrument measuring treatment adherence were employed. The data was analyzed using the Statistical Package for the Social Sciences and the Chi-squared and Fisher’s exact statistical tests. All the statistical tests applied a significance level of 5 %. Results: 202 patients were screened, 66.3 % of whom were classified as adherent. Patients with a clinical referral for valve replacement, a treatment time longer than five years, and an international normalized ratio (INR) value outside the therapeutic target showed greater adherence to treatment. In addition, having a sedentary lifestyle and the use of antiarrhythmic medication were significantly associated with adherence. Variables such as sex, income, occupation, level of education, and the presence of complications were not significantly associated with treatment adherence. Conclusion: This study’s findings highlight that adherence to treatment with anticoagulants hinges more on clinical factors and health behavior than on sociodemographic characteristics. Although traditionally studied, these are not necessarily reliable predictors of adherence. The essential factor seems to be more closely related to health education and medical and family support, which emphasizes the need for individualized support for these patients, with a focus on awareness and regular clinical follow-up.
Downloads
References
Ministério da Saúde (BR); Secretaria de Atenção Primária à Saúde; Departamento de Promoção da Saúde. Estratégia de Saúde Cardiovascular na Atenção Primária à Saúde: instrutivo para profissionais e gestores [recurso eletrônico]. Brasília: Ministério da Saúde; 2022. Disponível em: https://sisapsdoc.saude.gov.br/manual-evc-estrategia-cardio-vascular.pdf
Silva PGMB, Sznejder H, Vasconcellos R, Charles GM, Mendonça-Filho HT, Mardekian J et al. Anticoagulation therapy in patients with non-valvular atrial fibrillation in a private setting in Brazil: A real-world study. Arquivos Brasileiros de Cardiologia. 2020;114:457-66. DOI: https://doi.org/10.36660/abc.20180076
Gadde S, Kalluru R, Cherukuri SP, Chikatimalla R, Dasaradhan T, Koneti J. Atrial fibrillation in chronic kidney disease: An overview. Cureus. 2022;14(8). DOI: https://doi.org/10.7759/cureus.27753
Dorgalaleh A, Favaloro EJ, Bahrein M, Rad M. Standardization of prothrombin time/international normalized ratio (PT/INR). Int J Lab Hematol. 2021;43(1):21-8. DOI: https://doi.org/10.1111/ijlh.13349
Cannon CP, Kim JM, Lee JJ, Sutherland J, Bachireddy R, Valentine CM et al. Patients and their physician’s perspectives about oral anticoagulation in patients with atrial fibrillation not receiving an anticoagulant. JAMA Netw Open. 2023;6(4). DOI: https://doi.org/10.1001/jamanetworkopen.2023.9638
Nishino T, Narimoto K, Tominaga K, Sano M, Shimbo M, Muraishi N et al. A large adrenocortical adenoma surrounded with a renal arteriovenous malformation. IJU Case Reports. 2021;4(4):224-7. DOI: https://doi.org/10.1002/iju5.12293
Sousa WJFN, Guimarães NS, Viana CC, Medeiroa AF, Vianna MS, Bertollo CM. Fatores associados à não adesão ao uso de anticoagulantes orais: protocolo de revisão sistemática. Saúde Coletiva (Barueri). 2021;11(69):8618-34. DOI: https://doi.org/10.36489/saudecoletiva.2021v11i69p8618-8634
Richane A, Richane A, Ismail HB, Darej C, Moujahed N. Potential of Tunisian carob pulp as feed for ruminants: chemical composition and in vitro assessment. Tropical Animal Health and Production. 2022;54(1):58. DOI: https://doi.org/10.1007/s11250-022-03071-4
Al-Makki A, DiPette D, Whelton PK, Murad MH, Mustafa RH, Acharya S et al. Hypertension pharmacological treatment in adults: a World Health Organization guideline executive summary. Hypertension. 2022;79(1):293-301. DOI: https://doi.org/10.1161/HYPERTENSIONAHA.121.18192
Araújo GT, Simonetti SH, Conceição AP. Nursing interventions on oral anticoagulation therapy: An integrative review. Research, Society and Development. 2023;12(3). DOI: https://doi.org/10.33448/rsd-v12i3.40629
Santos FS, Da Rocha RZ, Da Silva Pereira P. Acolhimento da enfermagem em unidade básica de saúde no programa da hiperdia. Brazilian Journal of Implantology and Health Sciences. 2024;6(6):1248-62. DOI: https://doi.org/10.36557/2674-8169.2024v6n6p1248-1262
Salmasi S, Loewen P, Tandun R, Andrade JG, Vera MA. Adherence to oral anticoagulants among patients with atrial fibrillation: a systematic review and meta-analysis of observational studies. BMJ Open. 2020;10(4). DOI: https://doi.org/10.1136/bmjopen-2019-034778
Olaya Muñoz QX, Sánchez JGM, Ortiz RA, Bales CMT, Silvera G, Gorricho GA et al. Adesão e qualidade de vida em pacientes com fibrilação atrial e insuficiência cardíaca anticoagulados com Apixabana. Revista Uruguaya de Medicina Interna. 2023;8(3):59-69. DOI: https://doi.org/10.26445/08.03.6
Brucki SMD, Nitrini R, Caramelli P, Bertolucci PHF, Okamoto IH. Suggestions for utilization of the mini-mental state examination in Brazil. Arquivos de Neuropsiquiatria. 2003;61(3b):777-81. DOI: https://doi.org/10.1590/S0004-282X2003000500014
Carvalho ARS, Dantas RAS, Pelegrino FM, Corbi ISA. Adaptação e validação de uma medida de adesão à terapia de anticoagulação oral. Revista Latino-Americana de Enfermagem. 2010;18:301-8. Disponível em: https://www.redalyc.org/articulo.oa?id=281421933002
Delgado AB, Lima ML. Contributo para a validação concorrente de uma medida de adesão aos tratamentos. Psicologia, Saúde & Doenças. 2001;2(2):81-100. Disponível em: https://www.redalyc.org/articulo.oa?id=36220206
Braga MAF. Qualidade de vida relacionada à saúde de egressos da unidade de acidente vascular cerebral de hospital público de Belo Horizonte: um estudo longitudinal prospectivo. 2022. Tese (Doutorado em Enfermagem). Universidade Federal de Minas Gerais, Belo Horizonte; 2022.
Perreault S, Denus S, White-Guau B, Côté R, Schnnitzer ME, Dubé MP et al. Oral anticoagulant prescription trends, profile use, and determinants of adherence in patients with atrial fibrillation. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy. 2020;40(1):40-54. DOI: https://doi.org/10.1002/phar.2350
Corrochano M, Jiménez B, Millón J, Gich I, Rambla M, Gil E et al. Patient self-management of oral anticoagulation with vitamin K antagonists in everyday practice: clinical outcomes in a single centre cohort after long-term follow-up. BMC Cardiovascular Disorders. 2020;20:1-13. DOI: https://doi.org/10.1186/s12872-020-01448-7
Bavalia R, Middeldorp S, Weisser G, Espinola-Klein C. Treatment of venous thromboembolism in special populations with direct oral anticoagulants. Thrombosis and Haemostasis. 2020;120(06):899-911. DOI: https://doi.org/10.1055/s-0040-1710314
Lima PRG, Gonçalves GMS, Rodrigues RCM, Oliveira-Kumakura ARS. Fatores relacionados à adesão de pacientes ao uso de novos anticoagulantes orais. Revista da Escola de Enfermagem da USP. 2021;56. DOI: https://doi.org/10.1590/1980-220X-REEUSP-2021-0191
Sousa Borges TR, Da Silva Meyer MF, Simonetti SH. Adesão ao uso de anticoagulante oral cumarínico por pacientes portadores de fibrilação atrial. Nursing Edição Brasileira. 2021;24(274):5419-32. DOI: https://doi.org/10.36489/nursing.2021v24i274p5419-5432
Araújo HVS, Meira ACAP, Bem PHN, Anjos RCCBL, Bezerra SMMS, et al. Qualidade de vida de pacientes em tratamento com anticoagulante oral. Revista Eletrônica Acervo Saúde. 2021;13(3). DOI: https://doi.org/10.25248/reas.e6626.2021
Aikins J, Koomson A, Ladele M, Al-Nusair L, Ahmed A, Ashry A, et al. Anticoagulation and antiplatelet therapy in patients with prosthetic heart valves. Journal of Cardiac Surgery. 2020;35(12):3521-9. DOI: https://doi.org/10.1111/jocs.15034
Araújo RMM de, Oliveira FA de. Avaliação da efetividade da anticoagulação oral com varfarina em indivíduos atendidos no serviço de hematologia de um hospital público de referência em Fortaleza. (trabalho de conclusão de curso). Centro Universitário Fametro, Fortaleza; 2023. Disponível em: http://repositorio.unifametro.edu.br/handle/123456789/1662
Pagès A, Sabatier R, Sallerin B. Factors associated with the choice of oral anticoagulant class in older patients: An observational study. Journal of Cardiovascular Pharmacology and Therapeutics. 2020;25(4):332-7. DOI: https://doi.org/10.1177/1074248420917811
Brízido C, Ferreira AM, Lopes P, Strong C, Mendes GS, Gama FF et al. Adesão à terapêutica com anticoagulantes diretos em doentes com fibrilhação auricular não valvular–uma análise de mundo real. Revista Portuguesa de Cardiologia. 2021;40(9):669-75. DOI: https://doi.org/10.1016/j.repc.2020.10.017
Hachiro K, Takashima N, Suzuki T. Long-Term Outcomes After Aortic Valve Replacement for Aortic Valve Regurgitation ― Importance of Left Ventricular End-Systolic Diameter. Circulation Journal. 2024. Disponível em: https://www.jstage.jst.go.jp/article/circj/advpub/0/advpub_CJ-24-0081/_article/-char/ja/
Queiroz XSBA, Lira ALBC, Queiroz HEO, Oliveira SHS, Sodré NL, Santos ICRV et al. Barreiras na adesão terapêutica de indivíduos em uso de anticoagulantes orais: protocolo de revisão de escopo. Contribuciones a las Ciencias Sociales. 2024;17(3). DOI: https://doi.org/10.55905/revconv.17n.3-223
Lichota A, Szewczyk EM, Gwozdzinski K. Factors affecting the formation and treatment of thrombosis by natural and synthetic compounds. International Journal of Molecular Sciences. 2020;21(21):7975. DOI: https://doi.org/10.3390/ijms21217975
Khan F, Tritschler T, Kimpton M, Wells PS, Kearon C, Weitz JI et al. Long-term risk for major bleeding during extended oral anticoagulant therapy for first unprovoked venous thromboembolism: A systematic review and meta-analysis. Annals of Internal Medicine. 2021;174(10):1420-9. DOI: https://doi.org/10.7326/M21-109
Lo FMW, Wong EML, Hong FK. The effects of educational programs on knowledge, international normalized ratio, warfarin adherence, and warfarin-related complications in patients receiving warfarin therapy: an integrative review. Journal of Cardiovascular Nursing. 2022;37(3). DOI: https://doi.org/10.1097/JCN.0000000000000790
Araújo JA, Souza GC, Siqueira IFB, Cintra LP, Costa JM. Adesão à varfarina em pacientes atendidos em clínicas de anticoagulação do Brasil. Brazilian Journal of Health and Pharmacy. 2023;5(1):11-23. DOI: https://doi.org/10.29327/226760.5.1-2
Praxedes MFS, Silva JLP, Cruz AJA, Viana CC, Barbosa HC, Guimarães NS et al. Assessment of the relationship between the level of patient knowledge on warfarin therapy and the quality of oral anticoagulation: A systematic review and meta-analysis. PLoS One. 2023;18(8). DOI: https://doi.org/10.1371/journal.pone.0289836
Ozaki AF, Choi AS, Le QT, Ko DT, Han JK, Park SS et al. Real-world adherence and persistence to direct oral anticoagulants in patients with atrial fibrillation: A systematic review and meta-analysis. Circulation: Cardiovascular Quality and Outcomes. 2020;13(3). DOI: https://doi.org/10.1161/CIRCOUTCOMES.119.0059
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Xênia Sheila Barbosa Aguiar Queiroz, Nataly Lins Sodré, Isabel Cristina Ramos Vieira Santos, Maria Beatriz Araújo Silva, Rebeka Maria de Oliveira Belo, Simone Maria Muniz da Silva Bezerra
![Creative Commons License](http://i.creativecommons.org/l/by/4.0/88x31.png)
This work is licensed under a Creative Commons Attribution 4.0 International License.
1. Proposed Policy for Journals That Offer Open Access
Authors who publish with this journal agree to the following terms:
- The journal and its papers are published with the Creative Commons License Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0). You are free to share copy and redistribute the material in any medium or format if you: give appropriate credit, provide a link to the license, and indicate if changes were made; don’t use our material for commercial purposes; don’t remix, transform, or build upon the material.